This Pharma Company Is Selling a Decades-old Drug to Treat Muscular Dystrophy for $89000 – Fortune


Fortune

This Pharma Company Is Selling a Decades-old Drug to Treat Muscular Dystrophy for $89000
Fortune
Young Americans living with a devastating muscle disease in the U.S. face an a pproximately $88,000 price hike for a year’s worth of treatment that’s been around for decades. Illinois-based Marathon Pharmaceuticals will market deflazacort under the
Why Did That Drug Price Increase 6000%? It’s The LawForbes
An old drug gets a new price to fight a rare disease: $89000 a yearWashington Post
Marathon’s Drug Pricing Is Playing With FireBloomberg
Ars Technica –FiercePharma –Vocativ –FDA.gov
all 54 news articles »

View original article
Author:

Powered by WPeMatico